|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phytochemical screening and antimicrobial activities of plant extract of Lantana camara显示文摘 | PRADEEP B V TEJASWINI M NISHAL P | 2013 | Journal of Environmental Biology2013，34，3： | 1 |
| 2 | Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization显示文摘 | Kei Morohoshi Nishal Patel Masaharu Ohbayashi Victor Chong Hans E. Grossniklaus Alan C. Bird Santa J. Ono | 2011 | Experimental and Molecular Pathology2011，，1： | 1 |
| 3 | Highly stable integration of graphene Hall sensors on a microfluidic platform for magnetic sensing in whole blood显示文摘The detection and analysis of rare cells in complex media such as blood is increasingly important in biomedical research and clinical diagnostics.Micro-Hall detectors(μHD)for magnetic detection in blood have previously demonstrated ultrahigh sensitivity to rare cells.This sensitivity originates from the minimal magnetic background in blood,obviating cumbersome and detrimental sample preparation.However,the translation of this technology to clinical applications has been limited by inherently low throughput(<1 mL/h),susceptibility to clogging,and incompatibility with commercial CMOS foundry processing.To help overcome these challenges,we have developed CMOS-compatible graphene Hall sensors for integration with PDMS microfluidics for magnetic sensing in blood.We demonstrate that these grapheneμHDs can match the performance of the best publishedμHDs,can be passivated for robust use with whole blood,and can be integrated with microfluidics and sensing electronics for in-flow detection of magnetic beads.We show a proof-of-concept validation of our system on a silicon substrate and detect magnetic agarose beads,as a model for cells,demonstrating promise for future integration in clinical applications with a custom CMOS chip. | Nishal Shah Vasant Iyer Zhiping Zhang Zhaoli Gao Juhwan Park Venkata Yelleswarapu Firooz Aflatouni A.T.Charlie Johnson David Issadore | 2023 | Microsystems & Nanoengineering2023，9，3： | 1 |
| 4 | Phytochemical screening and antimicrobial activities of plant extract of Lantana ca- mara显示文摘 | PRADEEP B V TEJASWINI M NISHAL P | 2013 | J Environ Biol2013，34，3： | 1 |
| 5 | National Culture, Business Culture and Management Practices: Consequential Relationships?显示文摘 | Suku Bhaskaran Nishal Sukumaran | 2007 | Cross Cultural Management2007，，14： | 1 |
| 6 | 印与茶 人生的绝妙注解显示文摘品茗时玩味'壶小天地大'的哲理,刻印时面对'方寸之间,幻化万千'的世界。茶道以'和静'为禀性,治印追求整体的'和谐'之美。印与茗,不单是艺术共性上的'同而通之',更是一种互补中的相得益彰。这里对美的认同与回归,达到的是心境的涤荡与洗礼。 | 元白 Nishal | 2006 | 华人世界2006，，9： | 0 |
| 7 | Utilization of kinase inhibitors as novel therapeutic drug targets:A review显示文摘Kinase inhibitors are a significant and continuously developing division of target therapeutics.The drug discovery and improvement efforts have examined numerous attempts to target the signaling pathway of kinases.The Kinase inhibitors have been heralded as a game-changer in cancer treatment.For developing kinase inhibitors as a treatment for various non-malignant disorders like auto-immune diseases,is currently undergoing extensive research.It may be beneficial to investigate whether cell-specific kinase inhibitor administration enhances therapeutic efficacy and decreases adverse effects.The goal of the current review is to gain insight into the role of kinase inhibitors in facilitating effective target drug delivery for the treatment of various anti-inflammatory,auto-immune,and anticancer disorders.The aim of this review is also to shed light on drug discovery approaches for kinase inhibitors,their mode of action,and delivery approaches.The variation in the binding of kinases bestows different target approaches in drug design,which can be employed for designing the targeted molecules.Several target sites have been studied,exceeding the design of drugs for various diseases like cancer,Alzheimer’s,rheumatoid arthritis,etc.Diverse delivery approaches have also been studied for the targeted application of kinase inhibitors. | SUCHITRA NISHAL VIKAS JHAWAT SUMEET GUPTA PARMITA PHAUGAT | 2022 | Oncology Research2022，30，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员